Emisphere Technologies, Inc. announced the appointment of Alan L. Rubino to the position of President and Chief Executive Officer, effective immediately. Mr. Rubino has also been elected to the company's Board of Directors. Mr. Rubino's career spans over 30 years at every level of the biopharmaceutical industry.

Most recently, he was Chief Executive Officer and President of New American Therapeutics, Inc. The company also appointed Timothy G. Rothwell as Chairman of the Board of Directors. Mr. Rothwell is the former Chairman of Sanofi-Aventis U.S., having also served as President and Chief Executive Officer.